Inovio Pharmaceuticals(INO) - 2023 Q3 - Earnings Call Transcript

The research was recently featured on the Today Show, highlighting both the potential of DNA medicine and the power of partnerships to help accelerate progress for patients. We aim to continue building strategic partnerships like this one to drive medical progress for patients, innovation, and ultimately shareholder value. We also remain encouraged by the final data reported earlier this year from the study of INO-3112 in head and neck cancer in combination with a PD-L1 checkpoint inhibitor. We are continui ...